Scarica l'app Stockscreener
90.98
3.05%
2.69
Dopo l'orario di chiusura:
90.98
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVTY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$88.29
Aprire:
$89
Volume 24 ore:
1.21M
Relative Volume:
0.93
Capitalizzazione di mercato:
$10.56B
Reddito:
$2.77B
Utile/perdita netta:
$286.61M
Rapporto P/E:
38.71
EPS:
2.35
Flusso di cassa netto:
$524.11M
1 W Prestazione:
-2.57%
1M Prestazione:
+9.79%
6M Prestazione:
-4.09%
1 anno Prestazione:
-25.13%
Intervallo 1D:
$88.62
$91.44
Intervallo di 1 settimana:
$88.06
$94.64
Portata 52W:
$81.36
$129.50
Revvity Inc Stock (RVTY) Company Profile
Nome
Revvity Inc
Settore
Industria
Telefono
781-663-6900
Indirizzo
77 4TH AVENUE, WALTHAM
Confronta RVTY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
90.98 | 10.25B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-01 | Aggiornamento | UBS | Neutral → Buy |
| 2025-01-10 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-08 | Iniziato | Leerink Partners | Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-23 | Ripresa | Goldman | Buy |
Mostra tutto
Revvity Inc Borsa (RVTY) Ultime notizie
How Revvity Inc. (PKN) stock reacts to Fed tightening2025 Trading Volume Trends & Weekly High Return Stock Opportunities - newser.com
Revvity's Moat Rating Downgraded as Portfolio Transformations Weigh on Economic Returns - Morningstar
Revvity Closes Second Massachusetts Site, Increases Layoffs Amid Operational Consolidation - Boston Real Estate Times
Applying big data sentiment scoring on Revvity Inc.Weekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Can Revvity Inc. stock withstand economic slowdownJuly 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
Leerink Partners Adjusts Revvity Price Target to $120 From $110, Maintains Outperform Rating - MarketScreener
Why analysts remain bullish on Revvity Inc. stockPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
Will Revvity Inc. rebound enough to break evenWeekly Trend Summary & High Return Trade Opportunity Guides - newser.com
Sivik Global Healthcare LLC Purchases Shares of 45,000 Revvity Inc. $RVTY - MarketBeat
Revvity Inc. $RVTY Shares Bought by Triodos Investment Management BV - MarketBeat
Revvity, Inc. Experiences Evaluation Revision Amid Mixed Market Signals and Performance Challenges - Markets Mojo
Major Mass. biomanufacturer closes 2nd site, lays off more workers - The Business Journals
Medpace and Revvity Stocks Trade Down, What You Need To Know - TradingView
Revvity Inc. stock momentum explained2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Using fundamentals and technicals on Revvity Inc.Market Sentiment Summary & Verified Technical Trade Signals - newser.com
How to track smart money flows in Revvity Inc.IPO Watch & Safe Capital Growth Trade Ideas - newser.com
RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes - sharewise.com
Revvity Inc. stock trend outlook and recovery pathFed Meeting & Risk Managed Investment Strategies - newser.com
Will Revvity Inc. see short term momentumJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Best data tools to analyze Revvity Inc. stock2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Is Revvity Inc. stock a top pick for value investorsWeekly Trend Summary & AI Powered Market Trend Analysis - newser.com
Will Revvity Inc. (PKN) stock enhance shareholder valueWeekly Investment Recap & Stock Timing and Entry Methods - newser.com
Will Revvity Inc. stock sustain high P E ratios2025 Buyback Activity & Daily Profit Focused Screening - newser.com
Chart based analysis of Revvity Inc. trends2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
Revvity (RVTY): Evaluating Valuation Potential After Recent Modest Recovery in Share Price - Yahoo Finance
Evercore ISI Group Maintains Revvity (RVTY) Outperform Recommendation - Nasdaq
Evercore ISI Lowers Revvity (NYSE:RVTY) Price Target to $106.00 - MarketBeat
Evercore ISI Adjusts Revvity Price Target to $106 From $108, Maintains Outperform Rating - MarketScreener
Drake & Associates LLC Acquires 12,553 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity to Hold Earnings Call on Monday, October 27, 2025 - PharmiWeb.com
Revvity, Sanofi team on early Type 1 detection; Kihealth raises funds for diabetes test rollout - MedTech Dive
Is Revvity Inc. stock undervalued vs historical averagesBuy Signal & Community Verified Trade Alerts - newser.com
Revvity (RVTY) Is Up 11.9% After Announcing Sanofi Alliance to Expand Diabetes Diagnostics Portfolio - Sahm
What drives Revvity Inc stock priceShort-Term Trading Alerts & These Picks Are Just One Breakout Away - earlytimes.in
Can a trend reversal in Revvity Inc. lead to recoveryChart Signals & Stock Timing and Entry Methods - newser.com
Using AI based signals to follow Revvity Inc.Trade Volume Report & Risk Controlled Daily Trade Plans - newser.com
A Fresh Look at Revvity (RVTY) Valuation After Sanofi Partnership in Early Diabetes Screening - Sahm
Revvity to develop type 1 diabetes early detection assay with Sanofi - Investing.com Nigeria
Automated trading signals detected on Revvity Inc.Trade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Order flow analysis tools used on Revvity Inc.July 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
Lucem, Revvity partner with Sanofi for early T1D detection - BioWorld MedTech
Barclays Adjusts Revvity (RVTY) Price Target, Maintains Overweig - GuruFocus
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes - PharmiWeb.com
Barclays Maintains Revvity (RVTY) Overweight Recommendation - Nasdaq
Revvity Expands Type 1 Diabetes Program With Sanofi Support - Nasdaq
Sanofi (SNY) Supports Revvity's Expansion in Type 1 Diabetes Assay - GuruFocus
Revvity Launches Program to Expand Type 1 Diabetes Diagnosis Offering - MarketScreener
Barclays Adjusts Price Target on Revvity to $100 From $110, Maintains Overweight Rating - MarketScreener
Revvity Inc Azioni (RVTY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.61%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):